Levocarnitine Chloride

左卡尼汀氯化物

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevocarnitine Chloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCarnitine deficiencyMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQueen'S University
Active IndicationsCarnitine deficiency
Inactive IndicationsMetabolic Syndrome

Other Information

ATC CodeA16AA01
Related LinksDrugBankKEGG